IP Library Granted Patent US 10,188,793
Granted Patent B2
US 10,188,793 · App. 14/733,567 · Granted Jan 29, 2019

Insulin on board calculation, schedule and delivery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,188,793
App. No.
14/733,567
Granted
Jan 29, 2019
Kind
B2
Abstract

A system is provided with an insulin delivery device configured to deliver insulin to a user of the system and a computer-based control unit associated with the insulin delivery device. The computer-based control unit includes a user interface and a computer-based processor. The computer-based processor is configured to calculate a relative insulin on board value for a specific time by calculating a first value that represents a reference insulin on board value at the specific time, calculating a second value that represents an automated insulin on board value at the specific time, and subtracting one of the first and second values from the other. The automated insulin on board value represents at least one insulin delivery automatically specified by the computer-based control unit. Methods of use are also disclosed.

Claims (27)

1. An insulin delivery system comprising:

an insulin delivery device configured to deliver insulin to a user of the system; and

a computer-based control unit associated with the insulin delivery device, the computer-based control unit having a computer-based processor, wherein the computer-based processor is configured to:

calculate a relative insulin on board value for a specific time by calculating a first value that represents a reference insulin on board value at the specific time, calculating a second value that represents an automated insulin on board value at the specific time, and subtracting one of the first and second values from the other;

determine a future insulin delivery schedule over a period of time based in part on the calculated relative insulin on board value; and

configure the insulin delivery device to deliver insulin according to the determined future insulin delivery schedule, and

wherein the automated insulin on board value represents at least one insulin delivery automatically specified by the computer-based control unit.

2. The system of claim 1 , wherein the relative insulin on board calculation further includes adding a third value that represents a non-automated insulin on board value to the second value that represents an automated insulin on board value when calculating the second value, wherein a non-automated insulin on board value represents at least one insulin delivery manually specified by the user or a caregiver.

3. The system of claim 2 , wherein the relative insulin on board calculation takes into account one or more values representative of all insulin delivered to the user prior to the specific time that has not been completely absorbed by the user prior to the specific time, including any and all basal doses delivered to the user.

4. The system of claim 1 , further comprising a glucose monitor configured to measure glucose values of the user, wherein the glucose monitor is configured to automatically transfer the glucose values to the computer-based control unit, and wherein the computer-based control unit is configured with a mode to automatically control insulin delivery to the user through the insulin delivery device, thereby forming an automatic feedback control loop.

5. The system of claim 4 , wherein the computer-based processor is configured to calculate the relative insulin on board value by subtracting the first value from the second value.

6. The system of claim 4 , wherein the first value is representative of all insulin delivered according to a reference insulin delivery schedule and the second value is representative of all insulin delivered according to an automated insulin delivery schedule.

7. The system of claim 4 , wherein the reference insulin on board value is greater than the automated insulin on board value.

8. The system of claim 4 , further comprising a user interface on a display device, wherein the user interface is configured to present an indication of the relative insulin on board value to the user or a caregiver.

9. The system of claim 8 , wherein the indication of the relative insulin on board value is a relative insulin on board function over a time period.

10. The system of claim 9 , wherein at least a portion of the time period is a future time.

11. The system of claim 10 , wherein the user interface is configured to present a predicted change in glucose levels associated with the relative insulin on board function.

12. The insulin delivery system of claim 4 , wherein the computer-based control unit further comprises a bolus calculator configured to use the calculated relative insulin on board value to determine a bolus dosage.

13. The insulin delivery system of claim 1 , wherein the computer-based control unit further comprises a bolus calculator configured to use the calculated relative insulin on board value to determine a bolus dosage.

14. An insulin delivery device comprising:

an insulin delivery mechanism configured to deliver insulin to a user of the device; and

a computer-based control unit coupled to the insulin delivery mechanism to automatically deliver insulin to the user, the computer-based control unit having a computer-based processor, wherein the computer-based processor is configured to:

calculate a relative insulin on board value associated with a specific time period by calculating a first value that represents a reference insulin on board value associated with the specific time period, calculating a second value that represents an automated insulin on board value associated with the specific time period, and subtracting one of the first and second values from the other, wherein the automated insulin on board value represents at least one insulin delivery automatically specified by the computer-based control unit;

determine a future insulin delivery schedule over a period of time based in part on the calculated relative insulin on board value; and

configure the insulin delivery mechanism to deliver insulin according to the determined future insulin delivery schedule,

wherein the reference insulin on board value may be greater than the automated insulin on board value.

15. The insulin delivery device of claim 14 , wherein the computer-based control unit further comprises a bolus calculator configured to use the calculated relative insulin on board value to determine a bolus dosage.

Assignments (16)
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
SECURITY AGREEMENT SUPPLEMENT Recorded Sep 7, 2023
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 064840/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2023
From: BIGFOOT BIOMEDICAL, INC.
To: INSULET CORPORATION
Reel/Frame 062900/0001 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 062793/0316 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: MAZLISH, BRYAN
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 037504/0681 →